E-LIB Suche - Ergebnisse für: Meetze, Kristan

1

CLN-617 Retains IL2 and IL12 in Injected Tumors to Drive Ro..:

Mehta, Naveen K. ; Rakhra, Kavya ; Meetze, Kristan A....
Cancer Immunology Research. , 2024

Link: https://doi.org/10.1158/..

2

PB1847: A PHASE 1 STUDY TO INVESTIGATE CLN-049, A FLT3/CD3 ..:

Abdul-Hay, Maher ; Dinardo, Courtney ; Chan, Onyee...
HemaSphere. 7 (2023) S3 - p. e6508781 , 2023

Link: https://doi.org/10.1097/..

3

CLN-978, a novel half-life extended CD19/CD3/HSA-specific T..:

Meetze, Kristan ; Mehta, Naveen K ; Li, Bochong...
Journal for ImmunoTherapy of Cancer. 11 (2023) 8 - p. e007398 , 2023

Link: https://doi.org/10.1136/..

4

A novel IgG-based FLT3xCD3 bispecific antibody for the trea..:

Mehta, Naveen K ; Pfluegler, Martin ; Meetze, Kristan...
Journal for ImmunoTherapy of Cancer. 10 (2022) 3 - p. e003882 , 2022

Link: https://doi.org/10.1136/..

5

Profound, durable and MGMT‐independent sensitivity of gliob..:

Le Rhun, Emilie ; von Achenbach, Caroline ; Lohmann, Birthe...
International Journal of Cancer. 145 (2019) 1 - p. 242-253 , 2019

Link: https://doi.org/10.1002/..

6

Ned-170: A combination anti-cancer therapy targeting late s..:

Garmey, Edward Graeme ; Meetze, Kristan ; Martell, Bridget
Journal of Global Oncology. 5 (2019) suppl - p. 141-141 , 2019

Link: https://doi.org/10.1200/..

7

CBIO-01. TRANSCRIPTIONAL MODULATION OF BRACHYURY IN CHORDOM:

Seldomridge, Ashlee ; Sonnemann, Heather ; Jung, Jinkyu...
Neuro-Oncology. 19 (2017) suppl_6 - p. vi32-vi33 , 2017

Link: https://doi.org/10.1093/..

8

EXTH-62. TG02, A NOVEL TARGETING OF TRANSCRIPTION AND METAB..:

Su, Yu-Ting ; Chen, Robert ; Song, Hua...
Neuro-Oncology. 19 (2017) suppl_6 - p. vi86-vi86 , 2017

Link: https://doi.org/10.1093/..

9

PDTM-41. TG02, A NOVEL MULTIKINASE INHIBITOR, IS EFFECTIVE ..:

Wadhwa, Elizabeth ; Meetze, Kristan ; Nicolaides, Theo
Neuro-Oncology. 19 (2017) suppl_6 - p. vi198-vi199 , 2017

Link: https://doi.org/10.1093/..

10

EXTH-67. TG02, A BRAIN-PENETRANT MULTI-CDK INHIBITOR, POTEN..:

Tsang, Jonathan ; Sung, Sarah ; Gosa, Laura...
Neuro-Oncology. 19 (2017) suppl_6 - p. vi87-vi88 , 2017

Link: https://doi.org/10.1093/..

11

Antitumor activity of MLN8054, an orally active small-molec..:

Manfredi, Mark G. ; Ecsedy, Jeffrey A. ; Meetze, Kristan A....
Proceedings of the National Academy of Sciences. 104 (2007) 10 - p. 4106-4111 , 2007

Link: https://doi.org/10.1073/..

12

Antitumor Activity of MLN8054, an Orally Active Small-Molec..:

Manfredi, Mark G. ; Ecsedy, Jeffrey A. ; Meetze, Kristan A....
Proceedings of the National Academy of Sciences of the United States of America. 104 (2007) 10 - p. 4106-4111 , 2007

Link: https://www.jstor.org/st..

13

PB1847: A PHASE 1 STUDY TO INVESTIGATE CLN-049, A FLT3/CD3 ..:

Abdul-Hay, Maher ; Dinardo, Courtney ; Chan, Onyee...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10430354/. , 2023

Link: http://www.ncbi.nlm.nih...

14

CLN-978, a novel half-life extended CD19/CD3/HSA-specific T..:

Meetze, Kristan ; Mehta, Naveen K ; Li, Bochong..
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432633/. , 2023

Link: http://www.ncbi.nlm.nih...

15

A novel IgG-based FLT3xCD3 bispecific antibody for the trea..:

Mehta, Naveen K ; Pfluegler, Martin ; Meetze, Kristan...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8921914/. , 2022

Link: http://www.ncbi.nlm.nih...